Pharmaceutical Era

Search your requirement

  • Home
  • Press Releases
    • Submit Release
  • Events
  • Reach Us

Social media

Pharmaceutical Era Pharmaceutical Era
  • Home
  • Press Releases
    • Submit Release
  • Events
  • Reach Us
MilliporeSigma receives the industry
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Trailblazing 3D human liver models yield accurate MASH phenotype

Trailblazing 3D human liver models yield accurate MASH phenotype

Cure51 selects 10x Genomics Visium HD to drive its new drug discovery initiative

Cure51 selects 10x Genomics Visium HD to drive its new drug discovery initiative

  • 31 Oct 2024

French TechBio startup Cure51 and 10x Genomics, Inc., a leader in single cell and spatial biology,...

ProteoNic unveils Early Access Program, boosting viral vector titers with LV-2G UNic® technology

ProteoNic unveils Early Access Program, boosting viral vector titers with LV-2G UNic® technology

ImmunityBio Announces FDA Approval of ANKTIVA®,

ImmunityBio Announces FDA Approval of ANKTIVA®,

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System

Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

  • By Ro
  • Ro
  • 09 Apr 2026
Approval and Launch of Nintedanib Capsules

Approval and Launch of Nintedanib Capsules

  • By Dexcel Pharma USA
  • Dexcel Pharma USA
  • 09 Apr 2026
When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

  • By BD
  • BD
  • 07 Apr 2026
Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

  • By Curve Biosciences
  • Curve Biosciences
  • 07 Apr 2026
MEDIPEEL Gains Momentum in the K-Pharmacy Channel in Korea.

MEDIPEEL Gains Momentum in the K-Pharmacy Channel in Korea.

  • By MEDIPEEL
  • MEDIPEEL
  • 06 Apr 2026
Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

  • By Epia Neuro
  • Epia Neuro
  • 06 Apr 2026
Log in
Show
  • Create an account
  • Forgot your username?
  • Forgot your password?
Drug Discovery 2024
The Digital Pharma Advances Conference 2026

Most Popular

  • Matthew Fyfe has been appointed as Chief Scientific Officer as Outrun Therapeutics expands its leadership team
    Matthew Fyfe has been appointed as Chief Scientific Officer as Outrun Therapeutics expands its leadership team
    By Outrun Therapeutics
    Jan 13
  • European Commission Approves Alteogen’s Aflibercept Biosimilar, EYLUXVI® (ALT-L9)
    European Commission Approves Alteogen’s Aflibercept Biosimilar, EYLUXVI® (ALT-L9)
    By Alteogen Inc.
    Sep 17
  • To Target the Multi-Billion Dollar Kidney Disease Market, Mezzion Expands Its Udenafil Pipeline to ADPKD
    To Target the Multi-Billion Dollar Kidney Disease Market, Mezzion Expands Its Udenafil Pipeline to ADPKD
    By Mezzion Pharmaceuticals, Inc
    Jun 16
April   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

User Area

  • Login page
  • Registration
  • Edit Profile
  • Forgot Password

Discover

  • About Us
  • Terms Of Use
  • Privacy Policy
  • FAQs

Engage with Us

  • Search on Site
  • Post Press Release
  • Promote Brand
  • List Your Event

Subscribe for e-Newsletter Monthly

Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
loader
Antispam refresh
© Pharmaceutical Era — A product of HISSM. All Rights Reserved.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click here.